Park City Utah/ACCESSWIRE/4 August 2020/Phoenix Rising
Companies (FKA Resort Savers, Inc OTCQB:RSSV) has made
an addition to its Board of Directors
The Company is pleased to announce that Eric Fuller has joined
the Board of Directors. Eric brings a vast history of experience
and expertise in medical device and therapies markets in the US.
Eric has also been appointed VP of US Sales simultaneously with
this Board membership.
Since 1993 Eric has been a business operator in diagnostic
services, laser development for cosmetic medical purposes and
marketing of medical devices and therapies.
Eric’s relationships can assist the Company in developing US
sales for the Company’s planned infectious control acquisition(s)
or division. According to Market Insight Reports in a July 2020
release the worldwide market for Medical Disinfection and
Sterilization equipment will grow from 2,885 Billion USD in 2019
to 3,818.1 Billion in 2025.
He has developed many skills and contacts in the medical device
and ancillary industries. He is a well-known and liked presenter at
medical device conventions.
Eric has a long history of working with the FDA to obtain device
approval for US sales and usage.
DS Chang CEO stated “Eric brings a wealth of knowledge and
history of successes that will help lead Phoenix’s sales efforts into
the United States. At this time, we are looking down the road to
our anticipated needs for disinfectant sales in the US and Eric
could lead the way.”
For information on Phoenix Rising Companies visit www.phoenix-
This press release contains forward-looking statements. Known
and unknown risks may cause actual future results to vary widely.
The statements are based upon Management’s and Advisor’s
current expectations, estimates and projections; are not
guarantees of future performance and are subject to certain risks
and uncertainties and other factors, some of which are beyond
Management’s control and are difficult to predict. A reader of this
press release should not place undue reliance on forward-looking
statements. Investors should understand investing in shares of
RSSV involves a high degree of risk and should seek competent
investment advice prior to purchasing shares.